Related Experiment Video
Updated: Oct 9, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Microtubule/MAP-affinity regulating kinase (MARK) is activated by phenylarsine oxide in situ and phosphorylates tau
1Department of Psychiatry, University of Alabama at Birmingham, 35294-0017, USA. gvwj@uab.edu
Abstract:
Tau is a microtubule-associated protein (MAP) that is functionally modulated by phosphorylation and that is hyperphosphorylated in several neurodegenerative diseases. Because phosphorylation regulates both normal and pathological tau functioning, it is of interest to identify the signaling pathways and enzymes capable of modulating tau phosphorylation in vivo. Previously, it was demonstrated that in SH-SY5Y human neuroblastoma cells and rat primary cortical cultures tau is phosphorylated at Ser262/356, within its microtubule-binding domain, by a staurosporine-sensitive protein kinase in response to the vicinal thiol-directed agent phenylarsine oxide. The current study demonstrates the presence of a 100-kDa protein kinase activity in SH-SY5Y cells that associates with microtubules, phosphorylates tau at Ser262/356, is activated by phenylarsine oxide, and is inhibited by the protein kinase inhibitor staurosporine. Isolation of individual protein bands from a polyacrylamide gel revealed two closely spaced proteins containing Ser262/356-directed protein kinase activity. Mass spectrometry analysis indicated that these protein bands correspond to the 100-kDa microtubule/MAP-affinity regulating kinase (MARK), which has been shown previously to phosphorylate tau within its microtubule-binding domain. Immunoblot analysis of the protein kinase bands confirmed this finding, providing the first demonstration that activation of endogenous MARK results in increased tau phosphorylation within its microtubule-binding domain in situ.
Insights
Researchers identified a key enzyme, microtubule/MAP-affinity regulating kinase (MARK), responsible for tau phosphorylation in brain cells. This finding is crucial for understanding neurodegenerative diseases like Alzheimer's.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Tau protein phosphorylation is critical for normal brain function and implicated in neurodegenerative diseases.
- Previous studies showed tau phosphorylation at Ser262/356 by a staurosporine-sensitive kinase in response to phenylarsine oxide in neuronal cells.
Purpose of the Study:
- To identify the specific protein kinase responsible for tau phosphorylation at Ser262/356 in SH-SY5Y cells.
- To investigate the role of this kinase in tau phosphorylation in situ.
Main Methods:
- Biochemical assays to detect protein kinase activity in SH-SY5Y cell extracts.
- Protein isolation via gel electrophoresis and identification using mass spectrometry.
- Immunoblot analysis to confirm protein identity and phosphorylation status.
Main Results:
- A 100-kDa protein kinase activity associated with microtubules was identified in SH-SY5Y cells.
- This kinase phosphorylates tau at Ser262/356 and is activated by phenylarsine oxide.
- Mass spectrometry and immunoblot analysis identified the kinase as microtubule/MAP-affinity regulating kinase (MARK).
Conclusions:
- Endogenous MARK activation leads to increased tau phosphorylation at Ser262/356 within its microtubule-binding domain in situ.
- This study provides the first evidence for MARK's role in phosphorylating tau in its native cellular environment.
- Understanding MARK's function in tau phosphorylation may offer new therapeutic targets for neurodegenerative diseases.
More Related Videos
12:47Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
Published on: December 27, 2016
12:55Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Destabilization of Microtubules
Assembly of Complex Microtubule Structures
Drugs that Stabilize Microtubules
Microtubule Instability
PI3K/mTOR/AKT Signaling Pathway